Task: Answer the MCQ question.
Question: Which drug exhibits a -3.282\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CC(CN1CCN(C)CC1)OC(=O)c1ccc(Cl)cc1Cl.Cl
[b] Cc1ccc(S(=O)(=O)Nc2cc(C)cn(Cc3ccc(F)cc3)c2=O)cc1
[c] CC1CC(C)CN(CCCNC(=O)c2ccc3c(SCC(=O)O)c4c(nc3c2)CCC4)C1
Answer: a. CC(CN1CCN(C)CC1)OC(=O)c1ccc(Cl)cc1Cl.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(CN1CCN(C)CC1)OC(=O)c1ccc(Cl)cc1Cl.Cl
CC(CN1CCN(C)CC1)OC(=O)c1ccc(Cl)cc1Cl.Cl
1-(4-methylpiperazin-1-yl)propan-2-yl 2,4-dichlorobenzoate;hydrochloride